Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Rebecca Chambers, Ross Fitzgerald

Premium

Illumina has appointed Rebecca Chambers to senior director of investor relations. She joins the company from Myriad Genetics, where she was director of relations and corporate communications. Previously, she was senior manager of investor relations at Life Technologies. She holds an MBA from Cornell University and a BS in biology from John Carroll University.


Ross Fitzgerald, who is a group leader at the Roslin Institute in the UK, has been named chair in molecular biology at the University of Edinburgh. Fitzgerald's research focuses on using genomic and molecular tools to understand staphylococcal diseases, with the goal of identifying new therapeutic and diagnostic approaches.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.